Archive: Articles

Cannabis Isn’t Going Anywhere

By Adam Sharp on November 8, 2019

Cannabis stocks are down, but this industry is still booming. If you can ride out the bear market and buy the dip, you’ll be sitting pretty long term.
Summary Gold and bitcoin have had an interesting year. Bitcoin has outperformed gold in six out of the 10 months so far this year. Adam Sharp explains why it’s important to have both assets in your portfolio… and exactly how each should fit into your portfolio allocation… While bitcoin…

Startup Insider: How NowRx Works With Google Home

By Early Investing on November 7, 2019

In Part 2 of our interview with NowRx, we go behind the scenes to see how the company tracks orders, maps out delivery routes and more.

The Deep, Dark Hole of Drug Addiction

By Andy Gordon on November 6, 2019

The opioid crisis has taken thousands of lives. And Andy Gordon has experienced the damage firsthand. But there is hope for a better future.
Premium

Investing Outside of the Bay Area

By Adam Sharp on November 5, 2019

The Bay Area is losing its edge. Here’s where else you can find good startup deals.
Premium

Recommendation: Reinvest in NowRx

By Early Investing on November 4, 2019

Today’s Startup Insider video features the founders of NowRx, a startup that’s disrupting the brick-and-mortar pharmacy industry. In Part 1 of this interview, they discuss what they do, what inspired them to start the company and more.

Cannabis Companies Spend Record Amount on Lobbying

By Allison Brickell on November 4, 2019

Cannabis companies have spent a record amount on lobbying this year. Here’s why.
In this week’s Mailbag, the Early Investing team explains why altcoins are underperforming and how today’s startup deal flow is better than ever.

News Fix: Who Watches the Watchers?

By Vin Narayanan on November 2, 2019

In the news this week: Colleges become legal battlegrounds for cannabis, China praises blockchain and the Fix ponders who watches the watchers.

Buy Pot Stocks While Prices Are Low

By Adam Sharp on November 1, 2019

Marijuana stocks have taken a big hit across the board. That means they’re a great buying opportunity.
Premium

Preparing for Modern Monetary Theory

By Adam Sharp on November 1, 2019

It seems more and more likely that the Federal Reserve will begin printing money as a way to pay off the national debt. So it’s important to have exposure to certain alternative investments.

The Opioid Crisis Cost Us Almost $200 Billion Last Year

By Andy Gordon on October 30, 2019

The opioid crisis has cost American families, employers and the government billions of dollars. And we’re just beginning to see drug companies be held accountable. But there’s a silver lining.
Premium

Learning to Wait

By Adam Sharp on October 29, 2019

Here’s why patience is critically important in early-stage investing.
Premium
Cannabis is a brand-new industry filled with promising startups attacking all angles of the market. New products are hitting the shelves and attracting customers. And the U.S. cannabis market is already worth billions of dollars. But a brand-new market also comes with difficulties. Cannabis is still illegal at the…
Premium

Four States Gobble Up 80% of Venture Capital Dollars

By Vin Narayanan on October 28, 2019

Just four states receive 80% of all venture capital money. And 40% of all VC money raised goes to Facebook and Google ads. This is a stark reminder of just how broken the VC system is.

Everyone Is Googling CBD

By Allison Brickell on October 28, 2019

Americans are Googling cannabidiol and CBD more than ever. This increased interest is another reason we desperately need marijuana reform.